In a recent study, a novel developed liposomal nanoparticle loaded with anti-IL6R antibody which deliver to tumor microenvironment achieved a significant effect in inhibiting the metastasis of breast cancer cells in mouse models (76). Here, IL6R is linked to breast carcinoma.